Breaking News: LIVN – Market Insights, Analysis & Latest Updates

LIVN

Earnings call: LivaNova reports robust Q3 growth, raises 2024 outlook

LivaNova PLC reported 11% revenue growth in Q3 2024, driven by cardiopulmonary and epilepsy segments, raising 2024 guidance. Focus remains on innovation and market share expansion.

investing.com • 31/10/2024 - 11:25 AM

LIVN

LivaNova beats Q3 expectations, raises 2024 guidance

LivaNova PLC reports strong Q3 earnings, surpassing forecasts and raising 2024 revenue outlook, driven by growth in the Cardiopulmonary and Neuromodulation segments.

investing.com • 30/10/2024 - 10:40 AM

Greed and Fear Index

Note: The data is for reference only.

Greed

Earnings call: LivaNova reports robust Q3 growth, raises 2024 outlook

LivaNova beats Q3 expectations, raises 2024 guidance

Currency